. Author manuscript; available in PMC: 2011 Feb 28.

Published in final edited form as: Acta Neuropathol. 2009 Aug 19;119(2):221–233. doi: 10.1007/s00401-009-0583-3

Table 2.

Soluble Aβ40 and Aβ42 levels in temporal and occipital cortices of the core Alzheimer’s disease and nondemented control cases, as measured by ELISA. Aβ levels are presented relative to wet tissue weight (fmol Aβ/100μg wet weight tissue).

Group	Case	Temporal Cortex			Occipital Cortex
Group	Case	Aβ40	Aβ42	Total Aβ	Aβ40	Aβ42	Total Aβ
Alzheimer’s	AD1	21.63	0.13	21.76	24.56	2.42	26.98
	AD2	0.50	0.05	0.55	0.20	0.08	0.28
	AD3	0.08	0.04	0.12	0.02	0.06	0.08
	AD4	0.08	0.07	0.15	1.34	0.16	1.51
	AD5	1.59	0.09	1.68	n/a	n/a	n/a
	AD6	0.07	0.12	0.19	n/a	n/a	n/a
	AD7	0.01	0.01	0.04	2.80	0.51	3.31
	AD8	0.02	0.04	0.06	n/a	n/a	n/a
	AD9	0	0.03	0.03	0	0.05	0.05
	AD10	0	0.01	0.02	0.02	0.08	0.11
	AD means:	2.40	0.06	2.46	4.14	0.48	4.62
Nondemented	ND1	0	0.03	0.03	0.01	0.12	0.14
	ND2	0	0	0	0	0	0
	ND3	0	0.01	0.01	0	0	0
	ND means:	0.00	0.01	0.01	0.00	0.04	0.05